AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32794131 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 2
Study 32794131 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 2
Study 33184166 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline injectate (3 x 10 mL aliquots)
Number of subjects: 16
Study 33184166 — intervention group
Group type: COMPARATOR
Intervention: Sham injectates (3 x 10 mL)
Number of subjects: 16
Study 32383964 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium trajectories based on symptom severity and duration (measured using CAM-ICU and CAM-ICU-7 scales)
Number of subjects: 531
Study 35121091 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam (80 mg continuous intravenous infusion for 24 hours)
Number of subjects: 0
Study 35121091 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study 34274002 — intervention group
Group type: EXPERIMENTAL
Intervention: PAU-7S
Number of subjects: 321
Study 34274002 — intervention group
Group type: EXPERIMENTAL
Intervention: MVPA
Number of subjects: 321
Study 36241857 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 377
Study 36241857 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 377
Study 34090959 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 110
Study 34090959 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 110
Study 34090959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 32579403 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-MR
Number of subjects: 50
Study 32579403 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal biomarkers (calprotectin, lactoferrin, polymorphonuclear leukocyte elastase, S100A12, eosinophil-derived neurotoxin)
Number of subjects: 50
Study 36273313 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples Coping Enhancement Counseling (CCEC)
Number of subjects: 70
Study 36273313 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 70
Study 32700432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency combined with passive stretching (PRF-PS) exercise
Number of subjects: 62
Study 32700432 — intervention group
Group type: COMPARATOR
Intervention: Passive stretching (PS) exercise
Number of subjects: 62
Study 35020487 — intervention group
Group type: EXPERIMENTAL
Intervention: Transumbilical laparoscopic surgery (TULS)
Number of subjects: 80
Study 35020487 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic‐assisted surgery
Number of subjects: 80
Study 32867552 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-start donepezil (donepezil-to-donepezil)
Number of subjects: 98
Study 32867552 — intervention group
Group type: COMPARATOR
Intervention: Delayed-start (placebo-to-donepezil)
Number of subjects: 98
Study 32867552 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-start donepezil
Number of subjects: 98
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal behavior change strategies
Number of subjects: 308
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapersonal behavior change strategies
Number of subjects: 308
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program adapted for small groups
Number of subjects: 308
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: PA monitor
Number of subjects: 308
Study 33285280 — intervention group
Group type: COMPARATOR
Intervention: No interpersonal behavior change strategies
Number of subjects: 308
Study 33285280 — intervention group
Group type: COMPARATOR
Intervention: No intrapersonal behavior change strategies
Number of subjects: 308
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls
Number of subjects: 308
Study 33285280 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 308
Study 32189314 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural B vitamins (group N)
Number of subjects: 30
Study 32189314 — intervention group
Group type: COMPARATOR
Intervention: Synthetic B vitamins (group S)
Number of subjects: 30
Study 35598597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (TSA) at concentrations of 1 μg/mL, 10 μg/mL, 100 μg/mL, and 1 mg/mL plus 5 U/mL of thrombin
Number of subjects: 0
Study 35598597 — intervention group
Group type: COMPARATOR
Intervention: 5 U/mL of thrombin
Number of subjects: 0
Study 36354237 — intervention group
Group type: EXPERIMENTAL
Intervention: Posisep
Number of subjects: 2
Study 36354237 — intervention group
Group type: COMPARATOR
Intervention: PureRegen Gel (PRG)
Number of subjects: 2
Study 33301785 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine/Propofol
Number of subjects: 173
Study 33301785 — intervention group
Group type: COMPARATOR
Intervention: Atropine/Atracurium/Sufentanil
Number of subjects: 173
Study 32708973 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-rich diet (iron intake >20 mg/day)
Number of subjects: 22
Study 32708973 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) supplementation (105 mg/day)
Number of subjects: 22
Study 32708973 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-rich diet
Number of subjects: 22
Study 32708973 — intervention group
Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) supplementation
Number of subjects: 22
Study 33583683 — intervention group
Group type: EXPERIMENTAL
Intervention: FLASH curriculum (n = 10 schools)
Number of subjects: 1597
Study 33583683 — intervention group
Group type: COMPARATOR
Intervention: Knowledge-based sexual health curriculum (n = 10 schools)
Number of subjects: 1597
Study 35164846 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunset Without AIDS intervention group
Number of subjects: 450
Study 35164846 — intervention group
Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 450
Study 35164846 — intervention group
Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 450
Study 33124968 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilayer silicone foam dressings applied to the sacrum and coccyx (n = 300)
Number of subjects: 600
Study 33124968 — intervention group
Group type: COMPARATOR
Intervention: Standard care recommended by Japanese guidelines (control; n = 300)
Number of subjects: 600
Study 33433597 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt nicotine formulation (benzoic acid added)
Number of subjects: 119
Study 32390731 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training
Number of subjects: 12
Study 32390731 — intervention group
Group type: COMPARATOR
Intervention: Non-BFR training
Number of subjects: 12
Study 36098547 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental technique (Z350XT, 3M)
Number of subjects: 47
Study 36098547 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Filtek Bulk Fill, 3M)
Number of subjects: 47
Study 36098547 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Sonic Fill, Kerr)
Number of subjects: 47
Study 36098547 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Opus Bulk Fill, FGM)
Number of subjects: 47
Study 36098547 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study 33082202 — intervention group
Group type: EXPERIMENTAL
Intervention: Single negative HPV test
Number of subjects: 5537
Study 32438611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior (14.93 hours per day, SD = 1.76)
Number of subjects: 480
Study 32438611 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent on school assignments on weekends
Number of subjects: 480
Study 36351955 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient-based optimization method for determining expression patterns of functional channels in terms of whole‐cell ionic conductance (Gx)
Number of subjects: 0
Study 36351955 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Gxs of 4‐6 major ionic currents
Number of subjects: 0
Study 32357362 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol maleate (TTM) 0.5% solution for 12 months
Number of subjects: 42
Study 32357362 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol maleate (TTM) 0.5% solution
Number of subjects: 42
Study 32357362 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (control group)
Number of subjects: 42
Study 33486990 — intervention group
Group type: EXPERIMENTAL
Intervention: High TRAP exposure (30,000 particles/cm3 and 826 ng/m3)
Number of subjects: 77
Study 33486990 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium TRAP exposure (11,000 particles/cm3 and 409 ng/m3)
Number of subjects: 77
Study 33486990 — intervention group
Group type: EXPERIMENTAL
Intervention: Low TRAP exposure (2,500 particles/cm3 and 149 ng/m3)
Number of subjects: 77
Study 34670456 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow Music Group (SMG)
Number of subjects: 45
Study 34670456 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Music Group (FMG)
Number of subjects: 45
Study 34670456 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 45
Study 35621366 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multicomponent exercise intervention based on the integration of the Health Belief Model (HBM) and the Theory of Planned Behaviour (TPB)
Number of subjects: 0
Study 32463281 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cannabis (5.2% THC)
Number of subjects: 9
Study 32463281 — intervention group
Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 9
Study 32267471 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg, subcutaneously at weeks 0 and 4
Number of subjects: 507
Study 32267471 — intervention group
Group type: COMPARATOR
Intervention: Risankizumab
Number of subjects: 507
Study 32267471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study 36162893 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-visit root canal treatment with 2% chlorhexidine (CHX) as final irrigant
Number of subjects: 100
Study 36162893 — intervention group
Group type: COMPARATOR
Intervention: 2-visit root canal treatment with calcium hydroxide (CH) dressings
Number of subjects: 100
Study 32868661 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based cardiac rehabilitation program (S-CRP)
Number of subjects: 206
Study 32868661 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 206
Study 36029687 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 534
Study 36029687 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated Heparin
Number of subjects: 534
Study 34686402 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction during FNA breast biopsy
Number of subjects: 60
Study 34686402 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol without anesthetic during FNA breast biopsy
Number of subjects: 60
Study 33028480 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP + Treatment as Usual (TAU)
Number of subjects: 65
Study 33028480 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 65
Study 35390727 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended protein (RP + T)
Number of subjects: 136
Study 35390727 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein (HP + T)
Number of subjects: 136
Study 35390727 — intervention group
Group type: COMPARATOR
Intervention: Observational control (CON)
Number of subjects: 136
Study 33907936 — intervention group
Group type: EXPERIMENTAL
Intervention: One-implant group (n = 23)
Number of subjects: 47
Study 33907936 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-implant group (n = 24)
Number of subjects: 47
Study 33907936 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 47
Study 32211907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI) 2 mg (0.05 mL)
Number of subjects: 30
Study 32211907 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 30
Study 32211907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI)
Number of subjects: 30
Study 35700932 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician perception of patient goals
Number of subjects: 252
Study 35700932 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 252
Study 35700932 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with stable goals
Number of subjects: 252
Study 35700932 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent goals-of-care discussion
Number of subjects: 252
Study 32796329 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Buried Vertical Mattress Suture (MBVMS)
Number of subjects: 20
Study 32796329 — intervention group
Group type: COMPARATOR
Intervention: Buried Intradermal Suture (BIS)
Number of subjects: 20
Study 35488808 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG)
Number of subjects: 320
Study 35488808 — intervention group
Group type: COMPARATOR
Intervention: Standard Group (SG)
Number of subjects: 320
Study 35488808 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with initial severe mental fatigue (MFF)
Number of subjects: 320
Study 35488808 — intervention group
Group type: COMPARATOR
Intervention: Standard Group (SG) with initial severe mental fatigue (MFF)
Number of subjects: 320
Study 35488808 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with initial poor motivation
Number of subjects: 320
Study 35488808 — intervention group
Group type: COMPARATOR
Intervention: Standard Group (SG) with initial poor motivation
Number of subjects: 320
Study 35488808 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with chemotherapy
Number of subjects: 320
Study 35488808 — intervention group
Group type: COMPARATOR
Intervention: Standard Group (SG) with chemotherapy
Number of subjects: 320
Study 32809161 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic instruments
Number of subjects: 48
Study 32809161 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemostatic instruments
Number of subjects: 48
Study 35655233 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted non-surgical intervention (footwear, foot orthoses, foot exercises, advice, and self-management)
Number of subjects: 28
Study 35655233 — intervention group
Group type: COMPARATOR
Intervention: Advice and self-management alone
Number of subjects: 28
Study 35655233 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted non-surgical intervention
Number of subjects: 28
Study 32694318 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 32694318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 0
Study 32694318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 0
Study 36442482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic target <40th percentile)
Number of subjects: 124
Study 36442482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 124
Study 36442482 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 124
Study 33834643 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin plus anticholinergic (propiverine 5 mg)
Number of subjects: 99
Study 33834643 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin (monotherapy)
Number of subjects: 99
Study 32019343 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent-only
Number of subjects: 575
Study 32019343 — intervention group
Group type: COMPARATOR
Intervention: Balloon-stent
Number of subjects: 575
Study 35870327 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based treatment
Number of subjects: 96
Study 33492277 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmotech Training (DT) group
Number of subjects: 48
Study 33492277 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Weight Training (WT) group
Number of subjects: 48
Study 33492277 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 48
Study 33388227 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral vocal fold paralysis group (n=4)
Number of subjects: 10
Study 33388227 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cricoarytenoid joint dislocation group (n=4)
Number of subjects: 10
Study 33388227 — intervention group
Group type: COMPARATOR
Intervention: Normal group (n=2)
Number of subjects: 10
Study 34301613 — intervention group
Group type: EXPERIMENTAL
Intervention: brolucizumab 6 mg
Number of subjects: 69
Study 34301613 — intervention group
Group type: COMPARATOR
Intervention: aflibercept 2 mg
Number of subjects: 69
Study 34301613 — intervention group
Group type: EXPERIMENTAL
Intervention: brolucizumab
Number of subjects: 69
Study 34301613 — intervention group
Group type: COMPARATOR
Intervention: aflibercept
Number of subjects: 69
Study 33187542 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted problem-solving therapy
Number of subjects: 0
Study 33724637 — intervention group
Group type: EXPERIMENTAL
Intervention: ocrelizumab (OCR)
Number of subjects: 0
Study 33724637 — intervention group
Group type: COMPARATOR
Intervention: interferon
Number of subjects: 0
Study 33308807 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant core affect (pleasant pictures)
Number of subjects: 31
Study 33308807 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpleasant core affect (unpleasant pictures)
Number of subjects: 31
Study 35604678 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen media reduction intervention (≤3 hours per week for 2 weeks)
Number of subjects: 89
Study 35604678 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual screen media use)
Number of subjects: 89
Study 35604678 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen media reduction intervention
Number of subjects: 89
Study 35604678 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study 34266506 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant-formula-based complementary feeding pattern (CFP)
Number of subjects: 24
Study 34266506 — intervention group
Group type: COMPARATOR
Intervention: Breastmilk-based complementary feeding pattern (CFP)
Number of subjects: 24
Study 34266506 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant-formula-based CFP with high-Fe or mixed PBF
Number of subjects: 24
Study 34266506 — intervention group
Group type: COMPARATOR
Intervention: Low-Fe PBF
Number of subjects: 24
Study 33941140 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic urethrotomy
Number of subjects: 222
Study 33941140 — intervention group
Group type: COMPARATOR
Intervention: Open urethroplasty
Number of subjects: 222
Study 33059084 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation of quadriceps
Number of subjects: 104
Study 33059084 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (Control)
Number of subjects: 104
Study 36113889 — intervention group
Group type: COMPARATOR
Intervention: Education incentive
Number of subjects: 4389
Study 36113889 — intervention group
Group type: COMPARATOR
Intervention: Raffle and education incentive
Number of subjects: 4389
Study 36113889 — intervention group
Group type: COMPARATOR
Intervention: Raffle incentive
Number of subjects: 4389
Study 34472929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 57
Study 34472929 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 57
Study 34472929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 57
Study 34472929 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness Meditation (MM), Cognitive Therapy (CT), Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 57
Study 34031547 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a high‐efficiency particulate‐filtering respirator (PFR) for 48 hours
Number of subjects: 26
Study 34092640 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser photobiomodulation (904 nm, 60 mW/diode, 50 Hz) for 33 s to each of 21 points at the cranium and intra-orally, on one, two or three times/week for 4 weeks
Number of subjects: 22
Study 34092640 — intervention group
Group type: COMPARATOR
Intervention: Sham photobiomodulation (placebo)
Number of subjects: 22
Study 34092640 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser photobiomodulation
Number of subjects: 22
Study 34237764 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video on pain management
Number of subjects: 48
Study 34237764 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge pain medication instructions
Number of subjects: 48
Study 34250918 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 49
Study 34250918 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 49
Study 34250918 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement alone (Control)
Number of subjects: 49
Study 33396551 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (Mediterranean diet, exercise, vitamin D)
Number of subjects: 227
Study 35012708 — intervention group
Group type: EXPERIMENTAL
Intervention: ESS plus medical therapy
Number of subjects: 238
Study 35012708 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 238
Study 33032927 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 27
Study 33032927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 33032927 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 27
Study 35912517 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10 Hz rTMS (n = 27)
Number of subjects: 55
Study 35912517 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (n = 28)
Number of subjects: 55
Study 35912517 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 10 Hz rTMS
Number of subjects: 55